Skip to main content
Home ViewHub

Main Menu

  • About
  • Vaccine Data Explorer
    • COVID Vaccines
    • Haemophilus Influenzae Type B Vaccine
    • Human Papillomavirus Vaccine
    • Inactivated Polio Vaccine
    • Measles-containing-vaccine
    • Pneumococcal Conjugate Vaccine
    • Rotavirus Vaccine
    • Typhoid Conjugate Vaccine
  • Resources
  • Country Pages
  • Topic Pages

Resource Library

Our collection of quarterly reports, documentation, and resources. Use the filters below to sort and find what you are looking for more quickly.

Download Highlighted Document

A selection of recent and highlighted reports, documents, and resources
  • COVID-19 Vaccine Effectiveness Forest Plots: Omicron Variant of Concern
  • Duration of Protection of COVID-19 Vaccines Against Omicron
  • June 2023 VIEW-hub Report on Global Vaccine Introduction and Implementation
  • COVID-19 Vaccine Effectiveness Results Summary Table

Show Results by:

VoICE, the value of immunization compendium of evidence

Check out VoICE, VIEW-hub’s sister tool — a database of up-to-date information on the broader benefits of immunization.

Visit

Country Pages

Data Dictionary

The data dictionary contains the list of all variables available on VIEW-hub with names and descriptions.

  • Next Generation COVID-19 Vaccines
    Mar 7, 2023
    Briefs

    In partnership with the Asian Development Bank, IVAC summarized the landscape, benefits, and challenges of next generation COVID-19 vaccines.

  • January 2023 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Feb 22, 2023
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • PCV Product Serotypes
    Feb 11, 2023
    Results & Summaries

    This table shows the serotypes covered by the current pneumococcal conjugate vaccine products and the three additional products that are in the development pipeline. 

  • COVID-19 Duration of Protection Summary Table
    Dec 9, 2022
    Results & Summaries

    This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.

  • Effectiveness of COVID-19 Inactivated Vaccines Against Omicron
    Nov 17, 2022
    Briefs

    In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

  • Duration of Protection of COVID-19 Vaccines Against Omicron
    Nov 17, 2022
    Briefs

    In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

  • October 2022 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Nov 1, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • Effectiveness of COVID-19 mRNA Vaccines Against Omicron
    Oct 13, 2022
    Briefs

    In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

  • COVID-19 Vaccine Neutralization and Cellular Immunity Studies Review Methods
    Sep 10, 2022
    Methods

    This document outlines the methods used in the COVID-19 vaccines neutralization and cellular immunity studies review. 

  • July 2022 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Aug 2, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

Pagination

  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last
Showing 21 to 30 of 70 resources

ViewHub Logo

A project of:

 Johns Hopkins University School of Public Health and IVAC logo

Citation

International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub. www.view-hub.org. Accessed: .

Contact

Contact Us

If you have any questions or comments, or would like to notify us of any technical issues you are experiencing with VIEW-hub, please get in touch. We welcome and appreciate your valuable feedback.

Built by Graphicacy